The HIVdb system for HIV-1 genotypic resistance interpretation
- PMID: 22286876
- PMCID: PMC7068798
- DOI: 10.1159/000331998
The HIVdb system for HIV-1 genotypic resistance interpretation
Abstract
The Stanford HIV Drug Resistance Database hosts a freely available online genotypic resistance interpretation system called HIVdb to help clinicians and laboratories interpret HIV-1 genotypic resistance tests. These tests are designed to assess susceptibility to nucleoside and nonnucleoside reverse transcriptase inhibitors (NRTI and NNRTI), protease inhibitors and integrase inhibitors. The HIVdb genotypic resistance interpretation system output consists of (1) a list of penalty scores for each antiretroviral (ARV) resistance mutation in a submitted sequence, (2) estimates of decreased NRTI, NNRTI, protease and integrase inhibitor susceptibility, and (3) comments about each ARV resistance mutation in the submitted sequence. The application's strengths are its convenience for submitting sequences, its quality control analysis, its transparency and its extensive comments. The Sierra Web service is an extension that enables laboratories analyzing many sequences to individualize the format of their results. The algorithm specification interface compiler makes it possible for HIVdb to provide results using a variety of different HIV-1 genotypic resistance interpretation algorithms.
Copyright © 2012 S. Karger AG, Basel.
Similar articles
-
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge.Intervirology. 2012;55(2):102-7. doi: 10.1159/000331999. Epub 2012 Jan 24. Intervirology. 2012. PMID: 22286877
-
Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.J Clin Virol. 2005 Jul;33(3):224-9. doi: 10.1016/j.jcv.2004.06.014. Epub 2005 Jan 12. J Clin Virol. 2005. PMID: 15911444
-
Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.Intervirology. 2012;55(2):138-46. doi: 10.1159/000332013. Epub 2012 Jan 24. Intervirology. 2012. PMID: 22286884
-
Algorithms for the interpretation of HIV-1 genotypic drug resistance information.Antiviral Res. 2006 Sep;71(2-3):335-42. doi: 10.1016/j.antiviral.2006.05.003. Epub 2006 May 30. Antiviral Res. 2006. PMID: 16782210 Review.
-
Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.Scand J Infect Dis Suppl. 2003;106:75-8. Scand J Infect Dis Suppl. 2003. PMID: 15000590 Review.
Cited by
-
Processed HIV prognostic dataset for control experiments.Data Brief. 2021 May 14;36:107147. doi: 10.1016/j.dib.2021.107147. eCollection 2021 Jun. Data Brief. 2021. PMID: 34041323 Free PMC article.
-
Prediction and molecular field view of drug resistance in HIV-1 protease mutants.Sci Rep. 2022 Feb 21;12(1):2913. doi: 10.1038/s41598-022-07012-x. Sci Rep. 2022. PMID: 35190671 Free PMC article.
-
Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries.Pathogens. 2024 Jan 24;13(2):102. doi: 10.3390/pathogens13020102. Pathogens. 2024. PMID: 38392840 Free PMC article.
-
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV.J Clin Med. 2023 Dec 18;12(24):7759. doi: 10.3390/jcm12247759. J Clin Med. 2023. PMID: 38137828 Free PMC article.
-
Comprehensive Genetic Characterization of Four Novel HIV-1 Circulating Recombinant Forms (CRF129_56G, CRF130_A1B, CRF131_A1B, and CRF138_cpx): Insights from Molecular Epidemiology in Cyprus.Viruses. 2023 Dec 21;16(1):19. doi: 10.3390/v16010019. Viruses. 2023. PMID: 38275954 Free PMC article.
References
-
- Schapiro JM, Scherer J, Boucher CA, Baxter JD, Tilke C, Perno CF, et al. Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score. Antivir Ther. 2010;15:1011–1019. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical